Merck (purified corticotropin gel, corticotropin-zinc hydroxide) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Merck (purified corticotropin gel, corticotropin-zinc hydroxide) General Information

Description

New drug applications (NDAs) for purified corticotropin gel and corticotropin-zinc hydroxide. Corticotropin gel is a purified corticotropin (ACTH) in a sterile solution of gelatin for prolonged activity. Corticotropin-zinc hydroxide is a sterile aqueous suspension of purified corticotropin (ACTH) with zinc hydroxide for repository action. The products are approved for various disease states including multiple sclerosis, rheumatic disorders, dermatologic diseases, and a variety of collagen, ophthalmic, respiratory diseases as well as allergic and edematous states.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Primary Office
  • 2000 Galloping Hill Road
  • Kenilworth, NJ 07033
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Merck (purified corticotropin gel, corticotropin-zinc hydroxide) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Merck (purified corticotropin gel, corticotropin-zinc hydroxide)‘s full profile, request access.

Request a free trial

Merck (purified corticotropin gel, corticotropin-zinc hydroxide) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Merck (purified corticotropin gel, corticotropin-zinc hydroxide)‘s full profile, request access.

Request a free trial